Related references
Note: Only part of the references are listed.Immunotyping in tubo-ovarian high-grade serous carcinoma by PD-L1 and CD8+T-lymphocytes predicts disease-free survival
Akriti Bansal et al.
APMIS (2021)
Clinical and Prognostic Value of Antigen-Presenting Cells with PD-L1/PD-L2 Expression in Ovarian Cancer Patients
Anna Pawlowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Differential expression of PD-L1 between primary and metastatic epithelial ovarian cancer and its clinico-pathological correlation
Sandeep Kumar Parvathareddy et al.
SCIENTIFIC REPORTS (2021)
Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis
Chen Zhang et al.
FRONTIERS IN ONCOLOGY (2021)
PD-L1 Expression on Circulating Tumour-Derived Microvesicles as a Complementary Tool for Stratification of High-Grade Serous Ovarian Cancer Patients
Alessandra Battaglia et al.
CANCERS (2021)
PD-1 and PD-L1 expression on TILs in peritoneal metastases compared to ovarian tumor tissues and its associations with clinical outcome
Christine Bekos et al.
SCIENTIFIC REPORTS (2021)
Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives
Brigida Anna Maiorano et al.
CANCERS (2021)
Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)
Mayada Saad Farrag et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2021)
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer
Changxin Wan et al.
CANCER RESEARCH (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Laura Martin de la Fuente et al.
VIRCHOWS ARCHIV (2020)
PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Different Types of Tubo-Ovarian Carcinoma and Their Prognostic Value in High-grade Serous Carcinoma
Hao Chen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer
Brian Diskin et al.
NATURE IMMUNOLOGY (2020)
Checkpoint-inhibition in ovarian cancer: rising star or just a dream?
Klaus Pietzner et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2018)
Prognostic value of tumor PD-L1 expression combined with CD8+ tumor infiltrating lymphocytes in high grade serous ovarian cancer
Qiaohong Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer
Xinxin Zhu et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
PD-L1 expression in non-small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens
Jonas J. Heymann et al.
CANCER CYTOPATHOLOGY (2017)
The immunobiology of myeloid-derived suppressor cells in cancer
Morteza Motallebnezhad et al.
TUMOR BIOLOGY (2016)
Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma
Silvia Darb-Esfahani et al.
ONCOTARGET (2016)
PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer
John R. Webb et al.
GYNECOLOGIC ONCOLOGY (2016)
Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types
Giosue Scognamiglio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Tumor infiltrating lymphocytes in ovarian cancer
Phillip P. Santoiemma et al.
CANCER BIOLOGY & THERAPY (2015)
Classifying Cancers Based on T-cell Infiltration and PD-L1
Michele W. L. Teng et al.
CANCER RESEARCH (2015)
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
A. D'Incecco et al.
BRITISH JOURNAL OF CANCER (2015)
Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients
Johannes Landskron et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Tumor infiltrating and peritumoral T cells and expression of PD-L1 in BRCA1/2-mutated high grade serous ovarian cancers.
Kyle Strickland et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
Wei-Ting Hwang et al.
GYNECOLOGIC ONCOLOGY (2012)
Construction of High-Density Tissue Microarrays at Low Cost by Using Self-Made Manual Microarray Kits and Recipient Paraffin Blocks
Chang Hwan Choi et al.
KOREAN JOURNAL OF PATHOLOGY (2012)
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer
Junzo Hamanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)